Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

ACR-325 advances into phase II PoC studies in PD, bipolar disorder

June 30, 2008

Hisamitsu files for approval in Japan of HFT-290 in cancer pain

June 30, 2008

CHMP recommends approval of Abstral for breakthrough cancer pain

June 30, 2008

CHMP issues positive opinion for UCB's Vimpat in epilepsy

June 30, 2008

CHMP issues positive opinion for Cymbalta in generalized anxiety disorder

June 30, 2008

New class of amyloid-inhibiting agents described

June 30, 2008

Phase III data show tasimelteon significantly improves sleep in insomnia

June 27, 2008

Recent patents describe novel analgesic agents

June 27, 2008

UCB reports results preliminary results from phase IIa lacosamide trial

June 26, 2008

A.P. Pharma completes enrollment in phase III trial of APF-530 in CINV

June 25, 2008

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 3, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...
MicroRNAs in circulating extracellular vesicles as IPF biomarkers
BioWorld Science
MicroRNAs (miRNAs) are small noncoding RNAs gaining increasing attention due to their crucial role in gene expression regulation and influence in various cellular...
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...